The UK's National Health Service needs to form some kind of committee to evaluate the potential of diagnostic tests in order to take full advantage of advances in genomic medicine, says the Times Online's Mark Henderson. Two science think tanks at the University of Cambridge warn that "the potential of genetic testing to deliver better treatments at lower cost will be delayed unless there is a system to establish the benefits," Henderson says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.